# Lamictal TM, Haloperidol Decanoate in Schizophrenia

> **NCT00947375** · PHASE4 · TERMINATED · sponsor: **Central Mental Clinic for Outpatients of Baku City** · enrollment: 335 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Lamictal TM
- **DRUG:** Haloperidol Decanoate

## Key facts

- **NCT ID:** NCT00947375
- **Lead sponsor:** Central Mental Clinic for Outpatients of Baku City
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-01
- **Primary completion:** 2006-01
- **Final completion:** 2007-01
- **Target enrollment:** 335 (ACTUAL)
- **Why stopped:** All of the mentioned aim and objectives were achieved before the February 2007
- **Last updated:** 2009-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947375, "Lamictal TM, Haloperidol Decanoate in Schizophrenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00947375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*